- Report
- May 2025
- 182 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- December 2024
- 100 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- March 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- August 2024
- 161 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- January 2025
- 154 Pages
Global
From €2598EUR$2,900USD£2,214GBP
- Report
- May 2025
- 187 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- December 2024
- 110 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- May 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- June 2025
- 270 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 340 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Report
- February 2025
- 148 Pages
Global
From €3910EUR$4,365USD£3,333GBP
€4344EUR$4,850USD£3,703GBP
- Report
- November 2024
- 750 Pages
Global
From €1657EUR$1,850USD£1,413GBP
- Report
- November 2024
- 750 Pages
Global
From €1657EUR$1,850USD£1,413GBP
- Report
- April 2025
- 44 Pages
United States
- Report
- February 2025
- 218 Pages
Global
From €4298EUR$4,799USD£3,664GBP
- Report
- June 2025
- 151 Pages
Global
From €3135EUR$3,500USD£2,672GBP
- Report
- May 2025
- 199 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 187 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more